BNTX logo

BNTX
BioNTech SE - ADR

19,092
Mkt Cap
$22.99B
Volume
958,566.00
52W High
$124.00
52W Low
$79.52
PE Ratio
-15.49
BNTX Fundamentals
Price
$90.93
Prev Close
$90.36
Open
$89.97
50D MA
$94.53
Beta
0.85
Avg. Volume
856,275.85
EPS (Annual)
-$5.30
P/B
1.07
Rev/Employee
$414,872.02
$5,894.82
Loading...
Loading...

About

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7,807

Frequently Asked Questions

What is Market Cap of BioNTech SE - ADR?
What is the 52-week high for BioNTech SE - ADR?
What is the 52-week low for BioNTech SE - ADR?
What is BioNTech SE - ADR stock price today?
What was BioNTech SE - ADR stock price yesterday?
What is the PE ratio of BioNTech SE - ADR?
What is the Price-to-Book ratio of BioNTech SE - ADR?
What is the 50-day moving average of BioNTech SE - ADR?
How many employees does BioNTech SE - ADR have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available